Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

DOJ Tightens Oversight of DEI Programs: Implications for Rheumatology

  |  

The ACR will continue to actively monitor this development and respond as new details emerge on the policy’s implementation and potential impact on rheumatologists and their patients.

For further information about the ACR’s advocacy efforts, email the ACR’s advocacy team at [email protected]. ACR/ARP members can also schedule time to meet directly with the ACR’s advocacy team to discuss issues and challenges you are facing.

ADVERTISEMENT
SCROLL TO CONTINUE

Key Takeaways

  • The Department of Justice (DOJ) has released guidance regarding diversity, equity and inclusion programs and the application of federal anti-discrimination laws to entities who receive federal funds.
  • The guidance emphasizes that entities receiving federal funds must ensure compliance with federal law and avoid discrimination based on protected characteristics, regardless of the program’s labels, objectives or intentions.
  • The guidance provides a non-exhaustive list of unlawful practices that could lead to the revocation of grant funding.
  • The guidance includes best practices to help entities that receive federal funds avoid violating the law.

Related Articles
    melitas / shutterstock.com

    New ACR Subcommittee Will Advance Diversity, Equity & Inclusion

    Diversity, equity and inclusion (DEI) are the focus of a new ACR/ARP subcommittee of the Collaborative Initiatives (COIN) Special Committee. The 13-member group will explore strategies to increase diversity in the rheumatology workforce pipeline and reduce implicit bias in such organizational processes as speaker recruitment and abstract review. “There is a new awareness at the…

    Gorodenkoff / shutterstock.com

    The NIAMS Diversity Supplement Program Offers Researcher Funding

    The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is a component of the National Institutes of Health (NIH) that supports research into the causes, treatment and prevention of arthritis and musculoskeletal and skin diseases, as well as the training of basic and clinical scientists to carry out this research. NIAMS recognizes the…

    G-Stock Studio / shutterstock.com

    Conquering Systemic Racism in Medicine

    2020 has not only borne witness to a global pandemic, but also to increasing fervor in the fight for racial equity. In a wave of opposition to the systemic racism in the U.S., people have been in the streets demonstrating and protesting against social injustice and have taken to social media to promote political action….